Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada

UnknownOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Invasive Meningococcal Disease
Interventions
OTHER

surveillance

Trial Locations (13)

T3B 6A8

RECRUITING

Alberta Children's Hospital, Calgary

T6G 1C9

RECRUITING

Stollery Children's Hospital, Edmonton

V5Z 4H4

RECRUITING

BC Children's Hospital, Vancouver

R3E 3P4

RECRUITING

Children's Hospital Research Institute of Manitoba, Winnipeg

A1B 3V6

RECRUITING

Eastern Health Janeway Children's and Rehabilitation Centre, St. John's

B3K6R8

RECRUITING

IWK Health Centre, Halifax

K1H 8L1

RECRUITING

Children's Hospital of Eastern Ontario, Ottawa

M5G 1X8

RECRUITING

The Hospital for Sick Children, Toronto

H3T 1C5

RECRUITING

CHU- Sainte Justine, Montreal

H4A 3J1

RECRUITING

Montreal Children's Hospital, Montreal

G1V 4G2

RECRUITING

Centre Mere-Enfant Soleil CHU de Quebec, Québec

S7N 0W8

RECRUITING

Royal University Hospital, Saskatoon

L8S4K1

RECRUITING

McMaster's Children Hospital, Hamilton

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

Canadian Paediatric Society

OTHER